12:00 AM
Jan 02, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Pharmalgen regulatory update

The U.K.'s NICE issued final draft guidance recommending ALK-Abello's Pharmalgen to treat IgE-mediated bee and wasp venom allergy. The product is recommended for those who have...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >